Schedule 13D ownership disclosure

BOLT BIOTHERAPEUTICS INC

Security class unavailable · CUSIP: 097702104

Event date: 2021-02-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,754,437
Percent of class
8.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-023629
Form type
SC 13D
Filer
Bolt Biotherapeutics, Inc.
CIK
CIK 1641281
Filed
Feb 16, 2021
Reporting period
Feb 04, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub